Colesevelam clinical trials
Also written Welchol, IW-3718 and Cholestagel.
How each study uses colesevelam is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the colesevelam studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 26 May 2000 · WELCHOL · NDA 021141 (FDA, Drugs@FDA)
- European Union
- 9 Mar 2004 · Cholestagel · EMEA/H/C/000512 (EMA)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
51 studies that test it; most in 2009 (6)
| Year | Studies |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 4 |
| 2005 | 3 |
| 2006 | 1 |
| 2007 | 5 |
| 2008 | 1 |
| 2009 | 6 |
| 2010 | 4 |
| 2011 | 1 |
| 2012 | 2 |
| 2014 | 3 |
| 2015 | 1 |
| 2016 | 6 |
| 2017 | 1 |
| 2018 | 4 |
| 2019 | 2 |
| 2024 | 1 |
| 2026 | 3 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 23 · Other 28
Daiichi Sankyo (15) · Mayo Clinic (6) · Ironwood Pharmaceuticals, Inc. (5) · Hvidovre University Hospital (3) · University Hospital, Gentofte, Copenhagen (3) · Filip Krag Knop (2) · Genzyme, a Sanofi Company (2) · Lars Kristian Munck (1)
Often tested with
Tested in the same studies.
Metformin (3) · Chenodeoxycholic Acid (2) · Clonidine (1) · Niacin (1) · Liraglutide (1) · Thyroxine (1) · Glyburide (1) · Fenofibrate (1)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1
Studies that test colesevelam.
- Jul 2027Impact of Therapy Using Colesevelam Treatment Reducing Bile Acids in Patients With Fontan Circulation.Phase 1/2 · St. Boniface Hospital
Studies
Open first, then newest update. How each study uses colesevelam is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 51
- Impact of Therapy Using Colesevelam Treatment Reducing Bile Acids in Patients With Fontan Circulation.RecruitingPhase 1/2St. Boniface HospitalNCT06197763Written as ColesevelamHow we know
- Use of Bile Acid Binding Resins to Decrease PFAS Levels Via Colesevalem in Veterans StudyNot yet recruitingPhase 2University of Rhode IslandNCT07592858Written as ColesevelamHow we know
- Examining a Novel Gastrointestinal Intervention to Negate Environmental Toxicants (ENGINE)RecruitingPhase 1/2University of California, San FranciscoNCT07226440Written as ColesevelamHow we know
- Metabolic Effects of Endogenous Bile Acids After Gastric Bypass SurgeryRecruitingEarly Phase 1Hvidovre University HospitalNCT06925997Written as ColesevelamHow we know
- A Study of Colesevelam in Fecal IncontinenceCompletedPhase 3Mayo ClinicNCT02628626Written as ColesevelamHow we know
- Effect of the Sequestrant Colesevelam in Bile Acid DiarrhoeaCompletedPhase 4Lars Kristian MunckNCT03876717Written as Colesevelam HydrochlorideHow we know
- Evaluate Carotid Artery Plaque Composition by Magnetic Resonance Imaging in People Receiving Cholesterol MedicationCompletedPhase 4University of WashingtonNCT00715273Written as ColesevelamHow we know
- Treatment of Bile Acid Malabsorption With LiraglutideCompletedPhase 4Filip Krag KnopNCT03955575Written as ColesevelamHow we know
- A Trial of IW-3718 for 8 Weeks in Patients With Persistent Gastroesophageal Reflux Disease (GERD) Receiving Proton Pump Inhibitors (PPIs)TerminatedPhase 3Ironwood Pharmaceuticals, Inc.NCT03561090Written as IW-3718How we know
- Trial of IW-3718 for 8 Weeks in Patients With Persistent Gastroesophageal Reflux Disease (GERD) Receiving Proton Pump Inhibitors (PPIs)CompletedPhase 3Ironwood Pharmaceuticals, Inc.NCT03561883Written as IW-3718How we know
- Colesevelam for Children With Type 2 DiabetesCompletedPhase 4Daiichi SankyoNCT01258075Written as High-dose colesevelamHow we know
- Effect of Bile Acids and Bile Acid Sequstrants on GLP-1 Secretion After Roux-en-Y Gastric BypassCompletedPhase 4Hvidovre University HospitalNCT02952963Written as ColesevelamHow we know
- Effects of Bile Acids and Bile Acid Sequestrants on GLP-1 Secretion After Roux-en-Y Gastric BypassCompletedPhase 4Hvidovre University HospitalNCT02876484Written as ColesevelamHow we know
- Effects of Fish Oil and Colesevelam (STAIR7007)Status unknownNot applicableUniversity of ManitobaNCT01948648Written as ColesevelamHow we know
- Colesevelam Versus Placebo in the Treatment of Nonalcoholic SteatohepatitisCompletedPhase 2University of California, San DiegoNCT01066364Written as Colesevelam HclHow we know
- Trial to Understand Efficacy of Colesevelam in Diarrhea Predominant IBS Patients With Bile Acid MalabsorptionCompletedPhase 2Mayo ClinicNCT03270085Written as ColesevelamHow we know
- Randomized Trial Comparing Colesevelam vs. EzetimibeCompletedPhase 4LMC Diabetes & Endocrinology Ltd.NCT02682680Written as ColesevelamHow we know
- A Trial of IW-3718 for 8 Weeks in Patients With Symptomatic Gastroesophageal Reflux Disease (GERD)CompletedPhase 2Ironwood Pharmaceuticals, Inc.NCT02637557Written as IW-3718How we know
- Study to Evaluate the Effect of IW-3718 on the Pharmacokinetics of Oral Contraceptive, Levothyroxine, Glyburide, and Digoxin in Healthy Adult VolunteersCompletedPhase 1Ironwood Pharmaceuticals, Inc.NCT03856970Written as IW-3718How we know
- Bileacid Malabsorption and GLP-1 SecretionCompletedPhase 4University Hospital, Gentofte, CopenhagenNCT03009916Written as "cholestagel®" (Colesevelam)How we know
See all 51 studies that test colesevelam →
Given beside what is tested · 2 — colesevelam is usual care or a partner of the new treatment
- Three Antidiarrheal Strategies in HER2+/HR+ Early Breast Cancer Patients Treated With Extended Adjuvant NeratinibActive, not recruitingPhase 2Spanish Breast Cancer Research GroupNCT05252988Written as ColesevelamHow we know
- The Effects of Co-admin of Colesevelam and Sitagliptin on Glucose Metabolism in Subjects With Type 2 Diabetes MellitusCompletedNot applicableKineMedNCT01092663Written as Colesevelam HClHow we know
As the comparator · 1 — what is tested is compared with colesevelam
What changed recently
From the registry's own updates since Oct 20, 2026.
Started recruiting1
Codes
What other systems call colesevelam · ClinicalTrials.gg INT006596
- MeSH (NLM) D000069472Colesevelam HydrochlorideConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 1XU104G55NCOLESEVELAMConfirmed FDA, NLM, Wikidata
- RxNorm 141626Confirmed FDA, Wikidata
- Wikidata Q899036colesevelamConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C78056ColesevelamConfirmed FDA, Wikidata
- DrugBank DB00930One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000069472 | Colesevelam Hydrochloride | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 1XU104G55N | COLESEVELAM | Confirmed FDA, NLM, Wikidata |
| RxNorm | 141626 | — | Confirmed FDA, Wikidata |
| Wikidata | Q899036 | colesevelam | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C78056 | Colesevelam | Confirmed FDA, Wikidata |
| DrugBank | DB00930 | — | One source Wikidata |
Also registered as colesevelam hydrochloride (UNII P4SG24WI5Q · RxNorm 141625).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.